C-reactive protein levels in patients at cardiovascular risk: EURIKA study

類似資料

• Prevalence and treatment of atherogenic dyslipidemia in the primary prevention of cardiovascular disease in Europe: EURIKA, a cross-sectional observational study
  著者:: Halcox, Julian P., 等
  出版事項: (2017)
• Low Rates of Both Lipid-Lowering Therapy Use and Achievement of Low-Density Lipoprotein Cholesterol Targets in Individuals at High-Risk for Cardiovascular Disease across Europe
  著者:: Halcox, Julian P., 等
  出版事項: (2015)
• Rationale and methods of the European Study on Cardiovascular Risk Prevention and Management in Daily Practice (EURIKA)
  著者:: Rodríguez-Artalejo, Fernando, 等
  出版事項: (2010)
• Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: the EURIKA study
  著者:: Banegas, José R., 等
  出版事項: (2011)
• Excess risk attributable to traditional cardiovascular risk factors in clinical practice settings across Europe - The EURIKA Study
  著者:: Guallar, Eliseo, 等
  出版事項: (2011)